Celsion Corporation (NASDAQ:CLSN)

CAPS Rating: 1 out of 5

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.

Recs

0
Player Avatar rustam5 (77.30) Submitted: 12/27/2012 6:37:32 PM : Outperform Start Price: $36.00 CLSN Score: -89.22

Please let the trial be good.

Featured Broker Partners


Advertisement